ESR1 and breast carcinoma: Interestingly, SCUBE2 has been associated with ER/PR positive tumors 35 and proposed as a tumor suppressor in breast cancer,36 yet it has also been shown as the only common gene in outcome‐predictive signature assays in breast cancer.37